As of Jan 19
| -0.01 / -0.23%|
The 3 analysts offering 12-month price forecasts for VolitionRX Ltd have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 6.00. The median estimate represents a +132.56% increase from the last price of 4.30.
The current consensus among 3 polled investment analysts is to Buy stock in VolitionRX Ltd. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.